News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
734,030 Results
Type
Article (42663)
Company Profile (267)
Press Release (691086)
Multimedia
Podcasts (94)
Webinars (20)
Section
Business (207260)
Career Advice (2147)
Deals (35989)
Drug Delivery (128)
Drug Development (82022)
Employer Resources (176)
FDA (16556)
Job Trends (15062)
News (350400)
Policy (33177)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2622)
Accelerated approval (42)
Adcomms (25)
Allergies (160)
Alliances (49931)
ALS (196)
Alzheimer's disease (1755)
Antibody-drug conjugate (ADC) (370)
Approvals (16865)
Artificial intelligence (599)
Autoimmune disease (226)
Automation (50)
Bankruptcy (368)
Best Places to Work (11692)
BIOSECURE Act (20)
Biosimilars (204)
Biotechnology (175)
Bladder cancer (178)
Brain cancer (63)
Breast cancer (687)
Cancer (5322)
Cardiovascular disease (442)
Career advice (1820)
Career pathing (40)
CAR-T (299)
CDC (55)
Celiac Disease (2)
Cell therapy (801)
Cervical cancer (41)
Clinical research (70618)
Collaboration (1893)
Company closure (5)
Compensation (1270)
Complete response letters (72)
COVID-19 (2764)
CRISPR (98)
C-suite (997)
Cystic fibrosis (148)
Data (7051)
Decentralized trials (3)
Denatured (28)
Depression (157)
Dermatology (57)
Diabetes (550)
Diagnostics (6862)
Digital health (52)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (297)
Drug pricing (197)
Drug shortages (31)
Duchenne muscular dystrophy (272)
Earnings (92179)
Editorial (64)
Employer branding (21)
Employer resources (155)
Events (119391)
Executive appointments (1055)
FDA (19979)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1621)
Gene editing (211)
Generative AI (51)
Gene therapy (661)
GLP-1 (1031)
Government (4796)
Grass and pollen (6)
Guidances (396)
Healthcare (19102)
HIV (73)
Huntington's disease (52)
IgA nephropathy (91)
Immunology and inflammation (274)
Immuno-oncology (82)
Indications (157)
Infectious disease (3079)
Inflammatory bowel disease (203)
Inflation Reduction Act (14)
Influenza (129)
Intellectual property (275)
Interviews (338)
IPO (16793)
IRA (50)
Job creations (3689)
Job search strategy (1515)
JPM (59)
Kidney cancer (18)
Labor market (92)
Layoffs (562)
Leadership (35)
Legal (8078)
Liver cancer (98)
Longevity (29)
Lung cancer (713)
Lymphoma (406)
Machine learning (52)
Management (59)
Manufacturing (930)
MASH (179)
Medical device (13942)
Medtech (14021)
Mergers & acquisitions (20355)
Metabolic disorders (1416)
mRNA (177)
Multiple sclerosis (174)
NASH (17)
Neurodegenerative disease (387)
Neuropsychiatric disorders (99)
Neuroscience (3158)
Neurotech (1)
NextGen: Class of 2026 (6581)
Non-profit (4564)
Now hiring (73)
Obesity (667)
Opinion (286)
Ovarian cancer (185)
Pain (228)
Pancreatic cancer (258)
Parkinson's disease (341)
Partnered (33)
Patents (558)
Patient recruitment (588)
Peanut (60)
People (60200)
Pharmaceutical (61)
Pharmacy benefit managers (34)
Phase 1 (22015)
Phase 2 (31086)
Phase 3 (23167)
Pipeline (7118)
Policy (307)
Postmarket research (2607)
Preclinical (9338)
Press Release (66)
Prostate cancer (275)
Psychedelics (52)
Radiopharmaceuticals (309)
Rare diseases (998)
Real estate (6016)
Recruiting (72)
Regulatory (25203)
Reports (54)
Research institute (2434)
Resumes & cover letters (365)
Rett syndrome (32)
RNA editing (17)
RSV (85)
Schizophrenia (167)
Series A (269)
Series B (202)
Service/supplier (11)
Sickle cell disease (106)
Special edition (23)
Spinal muscular atrophy (166)
Sponsored (45)
Startups (3674)
State (2)
Stomach cancer (18)
Supply chain (118)
Tariffs (86)
The Weekly (64)
Vaccines (1073)
Venture capital (99)
Weight loss (425)
Women's health (110)
Worklife (19)
Date
Last 7 days (642)
Last 30 days (2459)
Last 365 days (30065)
2026 (8031)
2025 (30384)
2024 (35459)
2023 (40356)
2022 (51466)
2021 (55991)
2020 (54429)
2019 (46946)
2018 (35377)
2017 (32489)
2016 (31930)
2015 (37949)
2014 (31729)
2013 (26767)
2012 (29001)
2011 (29673)
2010 (27734)
Location
Africa (770)
Alabama (90)
Alaska (7)
Arizona (334)
Arkansas (14)
Asia (40275)
Australia (6608)
California (12293)
Canada (3518)
China (1238)
Colorado (531)
Connecticut (528)
Delaware (368)
Europe (87246)
Florida (1851)
Georgia (396)
Hawaii (3)
Idaho (62)
Illinois (959)
India (81)
Indiana (559)
Iowa (22)
Japan (487)
Kansas (129)
Kentucky (44)
Louisiana (38)
Maine (73)
Maryland (1483)
Massachusetts (8800)
Michigan (346)
Minnesota (675)
Mississippi (6)
Missouri (138)
Montana (33)
Nebraska (29)
Nevada (135)
New Hampshire (83)
New Jersey (3294)
New Mexico (28)
New York (3247)
North Carolina (1573)
North Dakota (8)
Northern California (6073)
Ohio (370)
Oklahoma (22)
Oregon (41)
Pennsylvania (2484)
Puerto Rico (26)
Rhode Island (50)
South America (1139)
South Carolina (76)
South Dakota (1)
Southern California (4838)
Tennessee (199)
Texas (1926)
United States (43584)
Utah (369)
Vermont (1)
Virginia (291)
Washington D.C. (82)
Washington State (981)
West Virginia (4)
Wisconsin (119)
Wyoming (2)
734,030 Results for "petvivo holdings inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024
February 12, 2025
·
3 min read
BioMidwest
PetVivo Reports Reports Fiscal 2024 Results
PetVivo Holdings, Inc., a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, reported results for the fiscal year ended March 31, 2024.
June 28, 2024
·
10 min read
Press Releases
Thermo Fisher Scientific Completes Acquisition of Clario Holdings, Inc.
March 24, 2026
·
7 min read
BioMidwest
PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Feline Tolerance to Intra-articular Injections of Spryng™ with OsteoCushion™ Technolgoy
PetVivo Holdings, Inc. announced that the Company has released the results of a clinical study conducted by Inotiv, Inc., a world-renowned independent clinical research organization, which examined the safety of intra-articular injections of collagen-elastin hydrogel microparticulates into the joints of cats.
February 7, 2024
·
4 min read
Press Releases
Reviva Pharmaceuticals Holdings, Inc. Announces Closing of $10 Million Public Offering
March 23, 2026
·
4 min read
Press Releases
Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026
March 25, 2026
·
1 min read
Press Releases
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering - March 18, 2026
March 18, 2026
·
4 min read
Press Releases
OSR Holdings, Inc. Granted 180-Day Nasdaq Extension; Reaffirms Strategic Momentum
March 5, 2026
·
3 min read
Press Releases
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
March 3, 2026
·
12 min read
Business
PetVivo Reports Second Quarter of Fiscal 2024 Financial Results
PetVivo Holdings, Inc. announces financial results for the three months ended September 30, 2023.
November 14, 2023
·
10 min read
1 of 73,403
Next
